|
AP646A
(en)
*
|
1995-03-27 |
1998-04-27 |
Sanofi Synthelabo |
Use of fumagillol and derivatives thereof for preparing medicaments against intestinal infections.
|
|
AU4808997A
(en)
*
|
1996-09-30 |
1998-04-24 |
Brigham And Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
AU3352799A
(en)
*
|
1997-10-31 |
1999-08-23 |
Children's Medical Center Corporation |
Method for regulating size and growth of vascularized normal tissue
|
|
ATE489108T1
(de)
*
|
1998-10-09 |
2010-12-15 |
Vegenics Ltd |
Flt4 (vegfr-3) als ziel für tumornachweis (imaging) und antitumortherapie
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
AU2003264378A1
(en)
*
|
2002-09-04 |
2004-03-29 |
Proteinexpress Co., Ltd. |
Embryo implantation inhibitor
|
|
WO2004103159A2
(en)
*
|
2003-05-14 |
2004-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating endometrium
|
|
WO2005004999A1
(en)
*
|
2003-07-14 |
2005-01-20 |
Fusion Sport International Pty Ltd |
Sports training and testing methods, apparatus and system
|
|
EP1687426B1
(en)
*
|
2003-08-29 |
2008-07-16 |
Children's Medical Center Corporation |
Antiangiogenicpeptides for treating or preventing endometriosis
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
JP2011523551A
(ja)
*
|
2008-05-15 |
2011-08-18 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
血管形成の調節の新規ターゲット
|
|
EP2140860A1
(en)
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
US8865746B2
(en)
*
|
2008-07-18 |
2014-10-21 |
Zafgen, Inc. |
Methods of treating an overweight or obese subject
|
|
WO2010012002A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Saryna Medical Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
WO2010065883A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Method of treating an overweight or obese subject
|
|
EP2486004B1
(en)
|
2009-10-09 |
2017-05-03 |
Zafgen, Inc. |
Sulphone compounds for use in the treatment of obesity
|
|
AU2011204267B2
(en)
|
2010-01-08 |
2015-12-03 |
Zafgen Corporation |
Fumagillol type compounds and methods of making and using same
|
|
US8815309B2
(en)
|
2010-01-08 |
2014-08-26 |
Zafgen, Inc. |
Methods of treating a subject with benign prostate hyperplasia
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
WO2011127304A2
(en)
|
2010-04-07 |
2011-10-13 |
Zafgen Corporation |
Methods of treating an overweight subject
|
|
WO2011130728A1
(en)
|
2010-04-17 |
2011-10-20 |
Bayer Healthcare Llc |
Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
|
|
EP2595628A1
(en)
|
2010-07-19 |
2013-05-29 |
Bayer HealthCare LLC |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
CN103249735B
(zh)
|
2010-07-22 |
2016-04-06 |
扎夫根股份有限公司 |
三环化合物及其制备和使用方法
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
WO2012075020A1
(en)
|
2010-11-29 |
2012-06-07 |
Zafgen Corporation |
Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
|
|
KR20140006888A
(ko)
|
2011-01-26 |
2014-01-16 |
자프겐 인크. |
테트라졸화합물, 그리고, 이를 제조하는 방법 및 이를 이용하는 방법
|
|
CN103534244B
(zh)
|
2011-03-08 |
2016-10-12 |
扎夫根股份有限公司 |
氧杂螺[2.5]辛烷衍生物及类似物
|
|
BR112013028666A2
(pt)
|
2011-05-06 |
2017-08-08 |
Zafgen Inc |
compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo
|
|
CA2835261C
(en)
|
2011-05-06 |
2019-06-04 |
Zafgen, Inc. |
Partially saturated tricyclic compounds and methods of making and using same
|
|
AU2012253759B2
(en)
|
2011-05-06 |
2016-01-21 |
Zafgen Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
JP2015509102A
(ja)
|
2012-01-18 |
2015-03-26 |
ザフゲン，インコーポレイテッド |
三環式スルホン化合物並びにその作製および使用方法
|
|
MX2014008706A
(es)
|
2012-01-18 |
2015-03-05 |
Zafgen Inc |
Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
|
|
US9260419B2
(en)
|
2012-05-07 |
2016-02-16 |
Zafgen, Inc. |
Polymorphic salt of a metap-2 inhibitor and methods of making and using same
|
|
AU2013259617A1
(en)
|
2012-05-08 |
2014-11-27 |
Zafgen, Inc. |
Treating hypothalamic obesity with MetAP2 inhibitors
|
|
MX356755B
(es)
|
2012-05-09 |
2018-06-11 |
Zafgen Inc |
Compuestos de tipo fumagilol y metodos para su elaboración y uso.
|
|
BR112015010223A2
(pt)
|
2012-11-05 |
2017-07-11 |
Zafgen Inc |
compostos tricíclicos para o uso no tratamento e/ou controle de obesidade
|
|
JP2015536981A
(ja)
|
2012-11-05 |
2015-12-24 |
ザフゲン，インコーポレイテッド |
三環式化合物ならびにその製造および使用方法
|
|
NZ707773A
(en)
|
2012-11-05 |
2019-05-31 |
Zafgen Inc |
Methods of treating liver diseases
|
|
CN105228610A
(zh)
|
2013-03-14 |
2016-01-06 |
扎夫根股份有限公司 |
治疗肾疾病和其它病症的方法
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|